dactinomycin has been researched along with Febrile Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esumi, S; Higashionna, T; Kitamura, Y; Murakawa, K; Sendo, T; Ushio, S | 1 |
| Azuma, H; Kobayashi, R; Sano, H; Sarashina, T; Suzuki, D; Toriumi, N; Yoshida, M | 1 |
1 trial(s) available for dactinomycin and Febrile Neutropenia
| Article | Year |
|---|---|
A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms | 2014 |
1 other study(ies) available for dactinomycin and Febrile Neutropenia
| Article | Year |
|---|---|
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung Cancer.
Topics: Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Febrile Neutropenia; Humans; Lung Neoplasms; Retrospective Studies; Treatment Outcome | 2022 |